Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Mérida E[au]:

Remission of Hematuria Improves Renal Survival in IgA Nephropathy. Sevillano AM et al. J Am Soc Nephrol. (2017)

Calciphylaxis: Beyond CKD-MBD. Fernández M et al. Nefrologia. (2017)

Should Asymptomatic Bacteriuria Be Systematically Treated in Kidney Transplant Recipients? Results From a Randomized Controlled Trial. Origüen J et al. Am J Transplant. (2016)

Search results

Items: 23

1.

NSAIDs and Nephrotic Syndrome.

Mérida E, Praga M.

Clin J Am Soc Nephrol. 2019 Sep 6;14(9):1280-1282. doi: 10.2215/CJN.08090719. Epub 2019 Aug 15. No abstract available.

PMID:
31416889
2.

General Assembly, Prevention, Operating Room Environment: Proceedings of International Consensus on Orthopedic Infections.

Aalirezaie A, Akkaya M, Barnes CL, Bengoa F, Bozkurt M, Cichos KH, Ghanem E, Darouiche RO, Dzerins A, Gursoy S, Illiger S, Karam JA, Klaber I, Komnos G, Lohmann C, Merida E, Mitt P, Nelson C, Paner N, Perez-Atanasio JM, Reed M, Sangster M, Schweitzer D, Simsek ME, Smith BM, Stocks G, Studers P, Talevski D, Teuber J, Travers C, Vince K, Wolf M, Yamada K, Vince K.

J Arthroplasty. 2019 Feb;34(2S):S105-S115. doi: 10.1016/j.arth.2018.09.060. Epub 2018 Oct 19. No abstract available.

PMID:
30348570
3.

IgA nephropathy: What patients are at risk of progression to end-stage renal disease and how should they be treated?

Praga M, Caravaca F, Yuste C, Cavero T, Hernández E, Morales E, Mérida E, Moreno JA, Sevillano A, Gutiérrez E.

Nefrologia. 2018 Jul - Aug;38(4):347-352. doi: 10.1016/j.nefro.2018.01.001. Epub 2018 Apr 7. English, Spanish. No abstract available.

4.

Heyde syndrome: Correction of anemia after aortic valve replacement in a hemodialysis patient.

Milla M, Hernández E, Mérida E, Yuste C, Rodríguez P, Praga M.

Nefrologia. 2018 May - Jun;38(3):327-329. doi: 10.1016/j.nefro.2017.05.002. Epub 2018 Mar 6. English, Spanish. No abstract available.

5.

Hyperkalemia of non-renal origin in a hemodialysis patient.

Rodríguez P, Mérida E, Hernández E, Milla M, Praga M.

Nefrologia. 2018 Jan - Feb;38(1):96-97. doi: 10.1016/j.nefro.2017.01.005. English, Spanish. No abstract available.

6.

Gastrointestinal complications induced by sevelamer crystals.

Yuste C, Mérida E, Hernández E, García-Santiago A, Rodríguez Y, Muñoz T, Gómez GJ, Sevillano Á, Praga M.

Clin Kidney J. 2017 Aug;10(4):539-544. doi: 10.1093/ckj/sfx013. Epub 2017 Apr 10.

7.

Remission of Hematuria Improves Renal Survival in IgA Nephropathy.

Sevillano AM, Gutiérrez E, Yuste C, Cavero T, Mérida E, Rodríguez P, García A, Morales E, Fernández C, Martínez MA, Moreno JA, Praga M.

J Am Soc Nephrol. 2017 Oct;28(10):3089-3099. doi: 10.1681/ASN.2017010108. Epub 2017 Jun 7.

8.

Calciphylaxis: Beyond CKD-MBD.

Fernández M, Morales E, Gutierrez E, Polanco N, Hernández E, Mérida E, Praga M.

Nefrologia. 2017 Sep - Oct;37(5):501-507. doi: 10.1016/j.nefro.2017.02.006. Epub 2017 Apr 5. English, Spanish.

9.

Universal Sustained Viral Response to the Combination of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with/without Ribavirin in Patients on Hemodialysis Infected with Hepatitis C Virus Genotypes 1 and 4.

Abad S, Vega A, Hernández E, Mérida E, de Sequera P, Albalate M, Macías N, Milla M, López-Gómez JM.

Am J Nephrol. 2017;45(3):267-272. doi: 10.1159/000454819. Epub 2017 Jan 7.

PMID:
28166520
10.

Effectiveness of direct-acting antivirals in Hepatitis C virus infection in haemodialysis patients.

Abad S, Vega A, Rincón D, Hernández E, Mérida E, Macías N, Muñoz R, Milla M, Luño J, López-Gómez JM.

Nefrologia. 2017 Mar - Apr;37(2):158-163. doi: 10.1016/j.nefro.2016.10.003. Epub 2016 Nov 30. English, Spanish.

11.

Should Asymptomatic Bacteriuria Be Systematically Treated in Kidney Transplant Recipients? Results From a Randomized Controlled Trial.

Origüen J, López-Medrano F, Fernández-Ruiz M, Polanco N, Gutiérrez E, González E, Mérida E, Ruiz-Merlo T, Morales-Cartagena A, Pérez-Jacoiste Asín MA, García-Reyne A, San Juan R, Orellana MÁ, Andrés A, Aguado JM.

Am J Transplant. 2016 Oct;16(10):2943-2953. doi: 10.1111/ajt.13829. Epub 2016 May 23.

12.

Malignant hypertension: a type of IgA nephropathy manifestation with poor prognosis.

Sevillano ÁM, Cabrera J, Gutiérrez E, Morales E, Mérida E, Huerta A, Cavero T, Hernández E, Moreno JA, Praga M.

Nefrologia. 2015;35(1):42-9. doi: 10.3265/Nefrologia.pre2014.Oct.12735. English, Spanish.

13.

Mycophenolate in refractory and relapsing lupus nephritis.

Rivera F, Mérida E, Illescas ML, López-Rubio E, Frutos MA, García-Frías P, Ramos C, Sierra M, Baltar J, Lucas J, Oliet A, Vigil A, Fernández-Juárez G, Segarra A, Praga M; Glomerular Spanish Glomerular Study Group (GLOSEN).

Am J Nephrol. 2014;40(2):105-12. doi: 10.1159/000365256. Epub 2014 Jul 30.

PMID:
25096639
14.

Modelling available crown fuel for Pinus pinaster Ait. stands in the "Cazorla, Segura and Las Villas Natural Park" (Spain).

Molina JR, Rodríguez y Silva F, Mérida E, Herrera MÁ.

J Environ Manage. 2014 Nov 1;144:26-33. doi: 10.1016/j.jenvman.2014.05.003. Epub 2014 Jun 6.

PMID:
24908612
15.

Mycophenolate as maintenance therapy for lupus nephritis with impaired renal function.

Rivera F, Illescas ML, López-Rubio E, Fulladosa J, Poveda R, Baltar J, Fernández-Juárez G, Ballarín J, Oliet A, Vigil A, Lucas J, Sierra M, Frutos MA, García-Frías P, Ramos C, Mérida E, Praga M, Segarra A.

Am J Nephrol. 2013;37(6):509-17. doi: 10.1159/000350756. Epub 2013 May 8.

PMID:
23689615
16.

Mycophenolate as induction therapy in lupus nephritis with renal function impairment.

Rivera F, Fulladosa X, Poveda R, Frutos MA, García-Frías P, Ara J, Illescas L, López-Rubio E, Mérida E, Carreño A, Ballarín J, Fernández-Juárez G, Baltar J, Ramos C, Pons S, Oliet A, Vigil A, Praga M, Segarra A; Spanish Group for the Study of Glomerular Disease (GLOSEN).

Am J Nephrol. 2012;35(5):424-33. doi: 10.1159/000337916. Epub 2012 Apr 20.

PMID:
22517244
17.

Renal transplantation in emigrants from Africa in Spain: similar results but different infectious profile compared with Spanish people.

Mérida E, Rodríguez A, Hernandez G, Huerta A, Gonzalez J, Hernández A, González E, Morales E, Praga M, Andrés A, Morales JM.

Transplant Proc. 2009 Jul-Aug;41(6):2363-5. doi: 10.1016/j.transproceed.2009.05.005.

PMID:
19715920
18.

When the finding of glomerular fibrils in patients with nephrotic syndrome leads to an erroneous diagnosis.

Huerta A, Segovia B, Hernández A, Morales E, González J, Mérida E, Angel Martínez M, Praga M.

NDT Plus. 2009 Feb;2(1):63-6. doi: 10.1093/ndtplus/sfn167. Epub 2008 Nov 12. No abstract available.

19.

[Glomerulopathies associated to HIV infection: a Spanish perspective].

Gutiérrez E, Morales E, Gutiérrez Martínez E, Manzanares MJ, Rosello G, Mérida E, Praga M.

Nefrologia. 2007;27(4):439-47. Spanish.

20.

GLP-1(7-36)amide binding in skeletal muscle membranes from streptozotocin diabetic rats.

Villanueva-Peñacarrillo ML, Delgado E, Vicent D, Mérida E, Alcántara AI, Valverde I.

Endocrine. 1995 Sep;3(9):685-7. doi: 10.1007/BF02746345.

PMID:
21153227
21.

Presence of glucagon and glucagon-like peptide-1-(7-36)amide receptors in solubilized membranes of human adipose tissue.

Mérida E, Delgado E, Molina LM, Villanueva-Peñacarrillo ML, Valverde I.

J Clin Endocrinol Metab. 1993 Dec;77(6):1654-7.

PMID:
8263154
22.

Presence and characterization of glucagon-like peptide-1(7-36) amide receptors in solubilized membranes of rat adipose tissue.

Valverde I, Mérida E, Delgado E, Trapote MA, Villanueva-Peñacarrillo ML.

Endocrinology. 1993 Jan;132(1):75-9.

PMID:
8380388
23.

Lipolytic action of glucagon-like peptides in isolated rat adipocytes.

Ruiz-Grande C, Alarcón C, Mérida E, Valverde I.

Peptides. 1992 Jan-Feb;13(1):13-6.

PMID:
1320261

Supplemental Content

Loading ...
Support Center